Eli Lilly (LLY) Asset Utilization Ratio (2009 - 2026)

Eli Lilly has reported Asset Utilization Ratio for 18 years, with the latest figure at 0.63 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 8.2% year-over-year to 0.63; the trailing twelve-month figure through Mar 2026 stood at 0.63 (up 8.2% YoY), and the FY2025 full-year result was 0.68, up 8.02% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.63, up from 0.57 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.63 in Q1 2026, with the low at 0.54 in Q1 2023.
• Historically, Asset Utilization Ratio has averaged 0.58 across 5 years, with a median of 0.57 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio advanced 12.35% — and 2023, when it slipped 11.94%.
• Eli Lilly's Asset Utilization Ratio stood at 0.59 in 2022, then fell by 4.93% to 0.56 in 2023, then gained by 4.28% to 0.58 in 2024, then fell by 1.8% to 0.57 in 2025, then increased by 10.05% to 0.63 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.63 (Q1 2026), 0.57 (Q4 2025), and 0.55 (Q3 2025), per Business Quant data.